Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
1,473.40
0.00 EUR
7.80 M EUR
1.49 B EUR
467.83 M
About ALS LIMITED
Sector
CEO
Malcolm Deane
Website
Headquarters
Brisbane
Founded
1910
ISIN
AU000000ALQ6
FIGI
BBG0035T6NG0
ALS Ltd. engages in the provision of analytical and testing services businesses and partnerships. It operates through the following segments: Life Sciences, Commodities, Industrial, and Other. The Life Sciences segment is involved in analytical testing data to assist consulting and engineering firms, industry, and governments in making informed decisions about environmental, food and pharmaceutical, electronics, consumer products, and animal health. The Commodities segment includes assaying and analytical testing and metallurgical services for mining and mineral exploration companies and provides specialist services to the coal industry such as coal sampling, analysis and certification, and formation evaluation services. The Industrial segment focuses on energy, resources, and infrastructure sectors with asset care and tribology testing services. The company was founded in 1863 and is headquartered in Brisbane, Australia.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
Depending on the exchange, the stock ticker may vary. For instance, on FWB exchange ALS LTD stocks are traded under the ticker CP4.
We've gathered analysts' opinions on ALS LTD future price: according to them, CP4 price has a max estimate of 10.91 EUR and a min estimate of 7.36 EUR. Watch CP4 chart and read a more detailed ALS LTD stock forecast: see what analysts think of ALS LTD and suggest that you do with its stocks.
Yes, you can track ALS LTD financials in yearly and quarterly reports right on TradingView.
ALS LTD is going to release the next earnings report on May 27, 2025. Keep track of upcoming events with our Earnings Calendar.
CP4 earnings for the last half-year are 0.19 EUR per share, whereas the estimation was 0.19 EUR, resulting in a 1.87% surprise. The estimated earnings for the next half-year are 0.20 EUR per share. See more details about ALS LTD earnings.
ALS LTD revenue for the last half-year amounts to 909.25 M EUR, despite the estimated figure of 904.84 M EUR. In the next half-year revenue is expected to reach 944.35 M EUR.
CP4 net income for the last half-year is 78.74 M EUR, while the previous report showed −72.89 M EUR of net income which accounts for 208.03% change. Track more ALS LTD financial stats to get the full picture.
ALS LTD dividend yield was 2.99% in 2023, and payout ratio reached 1.47 K%. The year before the numbers were 3.21% and 68.85% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Nov 27, 2024, the company has 19.57 K employees. See our rating of the largest employees — is ALS LTD on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. ALS LTD EBITDA is 259.01 M EUR, and current EBITDA margin is 26.06%. See more stats in ALS LTD financial statements.
Like other stocks, CP4 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade ALS LTD stock right from TradingView charts — choose your broker and connect to your account.